Harold Rogers sold Sanofi ADR (NASDAQ: SNY)
Harold Rogers (R-KY), a U.S. Representative, has disclosed 1 trade in Sanofi ADR (SNY) since 2014, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Harold Rogers sold $1,000 - $15,000 of Sanofi ADR (NASDAQ: SNY) on November 4, 2014. Since that trade, SNY is up +60.27% against the S&P 500 up +340.50%, an outperformance of -280.23%.
Data updated
Harold Rogers's SNY trades vs the price
SNY is up +60.27% since Harold Rogers sold on November 4, 2014, versus +340.50% for the S&P 500.
Performance since this trade
All Harold Rogers SNY trades
Harold Rogers & SNY trading FAQ
Is it legal for Harold Rogers to trade Sanofi ADR (SNY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Sanofi ADR (SNY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Harold Rogers sell SNY?
Harold Rogers disclosed a sale of $1,000 - $15,000 of Sanofi ADR (SNY) on November 4, 2014, according to public STOCK Act filings.
How has SNY performed since Harold Rogers's trade?
Since Harold Rogers sold SNY on November 4, 2014, the stock is up +60.27%, versus +340.50% for the S&P 500 over the same period, an outperformance of -280.23%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SNY trades?
Quantellect tracks every disclosed congressional trade in Sanofi ADR (SNY) on the Sanofi ADR congressional trading page, which aggregates filings across all members of Congress.
Harold Rogers's SNY tradesAll congressional filings for Sanofi ADRHarold Rogers's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.